(Q64128408)

5

object named as

O M Kew

0 references

author name string

C. F. Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659060

23 October 2022

L. De

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659060

23 October 2022

B. P. Holloway

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659060

23 October 2022

O. M. Kew

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659060

full work available at URL

23 October 2022

language of work or name

English

0 references

publication date

July 1991

0 references

https://api.elsevier.com/content/article/PII:0168170291901077?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

https://api.elsevier.com/content/article/PII:0168170291901077?httpAccept=text/plain

23 October 2022

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

23 October 2022

0 references

20

0 references

issue

2

0 references

page(s)

159-79

0 references

describes a project that uses

polymerase chain reaction

1 reference

based on heuristic

inferred from title

cites work

Reverse transcriptase and its associated ribonuclease H: interplay of two enzyme activities controls the yield of single-stranded cDNA

2

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies

23 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil

23 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides

23 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3

23 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction

23 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Three-dimensional structure of poliovirus at 2.9 A resolution.

23 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland.

23 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Polymerase chain reaction for human picornaviruses

23 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method

23 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences

23 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Partial RNA sequencing of eight supposed derivatives of type 3 poliovirus/USA/Saukett/50 reveals remarkable differences between three apparent substrains

23 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing

23 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee

23 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Antigenic structure of polioviruses of serotypes 1, 2 and 3

23 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome

23 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans

23 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Detection and differentiation of picornaviruses in clinical samples following genomic amplification

23 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus cross-absorbed antisera.

23 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains

23 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Geographic distribution of wild poliovirus type 1 genotypes.

23 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

History of Sabin attenuated poliovirus oral live vaccine strains

23 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

23 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

23 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines

23 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Shedding light on PCR contamination

23 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Purification and properties of poliovirus

23 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product

23 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1

23 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

23 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Intratypic Serodifferentiation of Poliomyelitis Virus Strains by Strain-Specific Antisera

23 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reactions

23 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0168-1702(91)90107-7

23 October 2022

Identifiers

0 references